- Home
- SCVL vs CVAC Comparison
SCVL vs CVAC Comparison
Compare SCVL & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCVL
- CVAC
- Stock Information
- Founded
- SCVL 1978
- CVAC 2000
- Country
- SCVL United States
- CVAC Germany
- Employees
- SCVL N/A
- CVAC N/A
- Industry
- SCVL Clothing/Shoe/Accessory Stores
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- SCVL Consumer Discretionary
- CVAC Health Care
- Exchange
- SCVL Nasdaq
- CVAC Nasdaq
- Market Cap
- SCVL 834.0M
- CVAC 812.1M
- IPO Year
- SCVL 1993
- CVAC 2020
- Fundamental
- Price
- SCVL $29.95
- CVAC $4.10
- Analyst Decision
- SCVL Buy
- CVAC Hold
- Analyst Count
- SCVL 2
- CVAC 3
- Target Price
- SCVL $51.00
- CVAC $10.00
- AVG Volume (30 Days)
- SCVL 456.6K
- CVAC 1.2M
- Earning Date
- SCVL 11-21-2024
- CVAC 11-12-2024
- Dividend Yield
- SCVL 1.80%
- CVAC N/A
- EPS Growth
- SCVL N/A
- CVAC N/A
- EPS
- SCVL 2.72
- CVAC N/A
- Revenue
- SCVL $1,220,115,000.00
- CVAC $70,565,734.00
- Revenue This Year
- SCVL $5.62
- CVAC $742.57
- Revenue Next Year
- SCVL $5.31
- CVAC N/A
- P/E Ratio
- SCVL $11.01
- CVAC N/A
- Revenue Growth
- SCVL 2.83
- CVAC 75.11
- 52 Week Low
- SCVL $24.94
- CVAC $2.22
- 52 Week High
- SCVL $46.92
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- SCVL 33.42
- CVAC 62.06
- Support Level
- SCVL $29.51
- CVAC $3.89
- Resistance Level
- SCVL $31.36
- CVAC $4.32
- Average True Range (ATR)
- SCVL 1.40
- CVAC 0.33
- MACD
- SCVL -0.21
- CVAC 0.03
- Stochastic Oscillator
- SCVL 9.78
- CVAC 54.27
About SCVL Shoe Carnival Inc.
Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. They operate their business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of our stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channel.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.